Effectiveness [qlco]
Antioxidant [phsu]
Vitamin C [orch, phsu, vita]
Reducing [qlco]
Myocardial [spco]
Infarct [patf]
size [spco]
Patients [podg]
Subject [grup]
Percutaneous coronary angioplasty NOS [topp]
Trial [resa]
Study Protocol [inpr]
Pilot [prog]
randomized [resa]
DOUBLE BLIND [resa]
Controlled [ftcn]
Trial [resa]
Background [cnce]
Acute myocardial infarction [dsyn]
Leading [tmco]
Mortality [qnco]
Oxidative Stress [comd]
Involved [ftcn]
Ischemia-Reperfusion Injury [inpo]
Acute myocardial infarction [dsyn]
Suggest [idcn]
Reperfusion [topp]
account [idcn]
Final [tmco]
size [spco]
Myocardial Infarct [dsyn]
Part [spco]
Damage [inpo]
Likely [qlco]
PREVENT [phsu]
Antioxidant [phsu]
Reinforcement [menp]
Vitamin C [orch, phsu, vita]
Supplementation [topp]
Ischaemia [dsyn]
Reperfusion Damage [inpo]
Decreasing [qlco]
Infarct [patf]
size [spco]
Trial [resa]
Prevention [topp]
Reperfusion Damage [inpo]
Associated [qlco]
Percutaneous coronary angioplasty NOS [topp]
Following [tmco]
Acute myocardial infarction [dsyn]
To [qlco]
Evaluate [ftcn]
Antioxidant [phsu]
Vitamin C [orch, phsu, vita]
Infarct [patf]
size [spco]
Patients [podg]
Subject [grup]
Percutaneous coronary angioplasty NOS [topp]
Acute myocardial infarction [dsyn]
Methods [inpr]
Design [acty]
This [euka]
randomized [resa]
DOUBLE BLIND [resa]
placebo [topp]
Controlled Clinical Trial [inpr]
Study [mnob]
Take [hlca]
Place [spco]
Two [qnco]
centers [spco]
Chile [geoa]
university hospital [hcro, mnob]
Chile [geoa]
Clinical [qlco]
San [gngm]
Clinical [qlco]
Hospital [hcro, mnob]
Subject [grup]
Adults [aggp]
Acute myocardial infarction [dsyn]
indication [idcn]
Percutaneous coronary angioplasty NOS [topp]
This [euka]
intervention [hlca]
Performed [ftcn]
Pilot Study [resa]
Involving [ftcn]
High dose [qnco]
Vitamin C [orch, phsu, vita]
Infusion [topp]
Administration, Oral [topp]
Vitamin E [lipd, phsu, vita]
Vitamin [orch, phsu, vita]
treatment [ftcn]
Group [idcn]
placebo [topp]
Control Group [grup]
Angioplasty [topp]
Procedure [diap, topp]
Vitamin [orch, phsu, vita]
treatment [ftcn]
Group [idcn]
Receive [qlco]
Oral [spco]
Dose [qnco]
Vitamin C [orch, phsu, vita]
Control Group [grup]
Receive [qlco]
placebo [topp]
days [tmco]
coronary angioplasty [topp]
Primary [qlco]
Outcome [ftcn]
Infarct [patf]
size [spco]
Assessed [acty]
Cardiac [bpoc]
Magnetic Resonance [npop]
Measured [qlco]
days [tmco]
coronary angioplasty [topp]
secondary [neop]
Outcome [ftcn]
ejection fraction [diap]
Measured [qlco]
days [tmco]
coronary angioplasty [topp]
Cardiac [bpoc]
Magnetic Resonance [npop]
Biomarkers [clna]
Oxidative Stress [comd]
Antioxidant [phsu]
Status [qlco]
Heart [bpoc]
Damage [inpo]
Inflammation [patf]
Measured [qlco]
baseline [bodm]
Onset [qlco]
Reperfusion [topp]
Revascularisation [topp]
hospital discharge [hlca]
Discussion [topp]
Ischaemia [dsyn]
Reperfusion [topp]
Event [evnt]
Occur [acty]
Angioplasty [topp]
Known [qlco]
To [qlco]
Increase [ftcn]
Myocardial Infarct [dsyn]
size [spco]
Benefits [qnco]
High dose [qnco]
Vitamin C [orch, phsu, vita]
Combined [qlco]
Vitamin E [lipd, phsu, vita]
Not [ftcn]
Trial [resa]
To [qlco]
therapeutic use [topp]
Vitamin C [orch, phsu, vita]
Reperfusion Damage [inpo]
Angioplasty [topp]
